CoChat

Pilot Study of the Effect of Methyl B12 Treatment on Behavioral and Biomarker Measures in Children with Autism

Bertoglio, Kiah, Jill James, S., Deprey, Lesley, Brule, Norman, Hendren, Robert L. · 2010 · The Journal of Alternative and Complementary Medicine
Cited by 109

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

OBJECTIVES: The study objectives were to determine whether methyl B12 treatment improves behavioral measures in children with autism and whether improvement is associated with increased plasma concentrations of glutathione (GSH) and an increased redox ratio of reduced glutathione to oxidized glutathione (GSH/GSSG), both of which have been previously identified to be low in children with autism. DESIGN: This was a 12-week, double-blind, placebo-controlled, cross-over clinical trial of injectable methyl B12. Following this 12-week study, subjects were given the option of entering a 6-month open-label trial of methyl B12. SETTINGS/LOCATION: All procedures took place at the UC Davis M.I.N.D. Institute. SUBJECTS: Subjects were 3 to 8 years old with autism. INTERVENTIONS: All subjects received 6 weeks of placebo and 6 weeks of methyl B12 at a dose of 64.5 mcg/kg every three days administered subcutaneously into the buttocks. OUTCOME MEASURES: Blood for GSH analysis and behavioral assessments were obtained at baseline, week 6, and week 12. RESULTS: Thirty (30) subjects completed the 12-week, double-blind study and 22 subjects completed the 6-month extension study. No statistically significant mean differences in behavior tests or in glutathione status were identified between active and placebo groups. Nine (9) subjects (30%) demonstrated clinically significant improvement on the Clinical Global Impression Scale and at least two additional behavioral measures. More notably, these responders exhibited significantly increased plasma concentrations of GSH and GSH/GSSG. CONCLUSIONS: Comparison of the overall means between groups suggests that methyl B12 is ineffective in treating behavioral symptoms of autism. However, detailed data analysis suggests that methyl B12 may alleviate symptoms of autism in a subgroup of children, possibly by reducing oxidative stress. An increase in glutathione redox status (GSH/GSSG) may provide a biomarker for treatment response to methyl B12. Additional research is needed to delineate a subgroup of potential responders and ascertain a biomarker for response to methyl B12.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/acm.2009.0177

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 19

  1. 10.1385/MN:28:1:1 · DOI · Paper page
  2. 10.1097/00125817-200209000-00013 · DOI
  3. 10.1111/j.1365-3016.2007.00801.x · DOI · Paper page
  4. 10.1542/peds.108.5.1155 · DOI · Paper page
  5. 10.1016/S0002-7138(09)60225-9 · DOI
  6. 10.1016/S0166-2236(03)00032-8 · DOI · Paper page
  7. 10.1038/labinvest.3780275 · DOI · Paper page
  8. 10.1093/ajcn/80.6.1611 · DOI · Paper page
  9. 10.1002/ajmg.b.30366 · DOI · Paper page
  10. 10.1007/BF02172145 · DOI · Paper page
  11. 10.1177/1362361303007001017 · DOI
  12. Guy W, 1976, ECDEU Assessment Manual for Psychopharmacology, Revised
  13. Dunn LM, 1981, Peabody Picture Vocabulary Test—Revised
  14. Roid GH, 2003, Stanford Binet Intelligence Scales
  15. Aman MG, 1985, Am J Ment Defic, 89, 485
  16. Achenbach T, 1983, Manual for the Child Behavior Checklist and Revised Child Behavior Profile
  17. Kanazawa S, 1985, Lab Invest, 53, 108
  18. 10.1016/0304-4165(77)90157-X · DOI
  19. 10.1373/clinchem.2003.019869 · DOI · Paper page

Cited by

See all 109

Metadata

Authors
Bertoglio, K., Jill James, S., Deprey, L., Brule, N., & Hendren, R. L.
Venue
The Journal of Alternative and Complementary Medicine
Published
2010-05
Volume
16
Issue
5
Pages
555-560
ISSN
  • 1075-5535 (ISSN-L)
  • 1557-7708
OpenAlex
W2022143207
Cited by
109
References
5
FWCI
3.26
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.